Ignacio
Matos García
Consultor Médico
Complejo Hospitalario de Toledo
Toledo, EspañaPublications in collaboration with researchers from Complejo Hospitalario de Toledo (1)
2017
-
Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)
European Journal of Endocrinology, Vol. 177, Núm. 4, pp. 309-317